Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
128.1M
Cash
18.12M
Avg Qtr Burn
-3.618M
Short % of Float
15.75%
Insider Ownership
53.26%
Institutional Own.
11.75%
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
NXP800 Details Ovarian cancer, Cancer | Phase 1b Data readout | |
NXP800 Details Cancer, Cholangiocarcinoma | Phase 1 Data readout | |
NXP900 Details Cancer, Squamous cancers, Solid tumor/s | Phase 1a Data readout |